ESMO Sarcoma and Rare Cancers 2023 | Key highlights from ESMO Sarcoma and Rare Cancers 2023

Piotr Rutkowski, MD, PhD, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland, reflects on his main highlights from ESMO Sarcoma and Rare Cancers Congress 2023 including presentations on MDM2 and EZH2 mutations in liposarcoma and Ewing sarcoma, respectively. Prof. Rutkowski also discusses data from his team investigating the influence of the pandemic on bone sarcoma intensity and tumor size. This interview took place at the ESMO Sarcoma and Rare Cancers Congress 2023 in Lugano, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.